Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine in autism spectrum disorder
IRCT2016022826802N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of atomoxetine in Autism Spectrum Disorder (ASD), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Started Aug 2015; status: completed.
02
Drugs
atomoxetine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT2016022826802N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016022826802N1.